Maria J. Valkema

Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial

Berend J. van der Wilk, Ben M. Eyck, Bas P. L. Wijnhoven et al. · The Lancet Oncology · 2025 · 61 citations · Full text

Surgical Oncology, Neoadjuvant Chemoradiotherapy, Esophageal Cancer +12

LBA75 Neoadjuvant chemoradiotherapy followed by surgery versus active surveillance for oesophageal cancer (SANO-trial): A phase-III stepped-wedge cluster randomised trial

Berend J. van der Wilk, Ben M. Eyck, Bas P. L. Wijnhoven et al. · Annals of Oncology · 2023 · 49 citations · Full text

Lba75 Neoadjuvant Chemoradiotherapy, Surgical Oncology, Esophageal Cancer +9

Accuracy of ¹⁸F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

Maria J. Valkema, Bo Jan Noordman, Bas P. L. Wijnhoven et al. · Journal of Nuclear Medicine · 2019 · 36 citations · Full text

A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2

Charlène J. van der Zijden, Sjoerd M. Lagarde, Merel Hermus et al. · BMC Cancer · 2023 · 24 citations · Full text

Surveillance of Clinically Complete Responders Using Serial ¹⁸F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy

Maria J. Valkema, Berend J. van der Wilk, Ben M. Eyck et al. · Journal of Nuclear Medicine · 2020 · 15 citations · Full text